Therapeutic vectors of treatment of ovarian endometriomas

In: HEALTH OF WOMAN · 2018 · pp. 83–86 · doi:10.15574/hw.2018.130.83 · W3146595977
article OA: diamond CC0

Abstract

The objective: to study clinical and anamnesis features in patients with ovarian endometriomas and to improve existing algorithms of treatment women with ovarian endpmetriomas. Materials and methods. The study included 32 patients aged 18 – 49 years with ovarian endometriomas and 50 healthy women. A general clinical, sonographic, immunological examination was conducted. Results. The analysis of the study data revealed the I degree of insufficiency of the adaptive link and the I–II degree of insufficiency of the nonspecific link of the immune system. In 74.51% of cases surgical treatment of the pathological process was carried out. As a conservative therapy and in the postoperative period the patients received complex therapy with immunomodulators, drugs of indole-3-carbinol, combined oral contraceptives with gestagen. Conclusion. The application of our proposed complex therapy of ovarian endometriomas in women of reproductive age showed a high recovery rate and a low relapse rate. Key words: ovarian endometrioma, reproductive age, immune dysfunction, treatment.

My notes (saved in your browser only)

Condition tags

endometrioma

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK